Does BINIMETINIB Cause Product use in unapproved indication? 508 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 508 reports of Product use in unapproved indication have been filed in association with BINIMETINIB (MEKTOVI). This represents 7.4% of all adverse event reports for BINIMETINIB.
508
Reports of Product use in unapproved indication with BINIMETINIB
7.4%
of all BINIMETINIB reports
86
Deaths
64
Hospitalizations
How Dangerous Is Product use in unapproved indication From BINIMETINIB?
Of the 508 reports, 86 (16.9%) resulted in death, 64 (12.6%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BINIMETINIB. However, 508 reports have been filed with the FAERS database.
What Other Side Effects Does BINIMETINIB Cause?
Off label use (902)
Death (719)
Nausea (657)
Fatigue (562)
Diarrhoea (521)
Pyrexia (490)
Neoplasm progression (387)
Vomiting (375)
Rash (360)
Serous retinal detachment (299)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which BINIMETINIB Alternatives Have Lower Product use in unapproved indication Risk?
BINIMETINIB vs BIOFLAVONOIDS
BINIMETINIB vs BIOTIN
BINIMETINIB vs BIPERIDEN
BINIMETINIB vs BIRCH TRITERPENES
BINIMETINIB vs BISACODYL